Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03773393 · ClinicalTrials.gov registry record · Phase 1
A Clinical Trial of CK0801 (a New Drug) in Patients With Bone Marrow Failure Syndrome (BMF)
A Phase 1 study of Bone Marrow Disease, sponsored by Cellenkos.
- Active
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
- 2
- Study locations
NCT03773393 is a Phase 1 study of Bone Marrow Disease that is active but no longer recruiting, run by Cellenkos. The registered enrollment target is 18 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT03773393, a Phase 1 study of Bone Marrow Disease, is active but no longer recruiting, sponsored by Cellenkos.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical research study is to determine whether it is safe and practical to give CK0801 (a Cord blood-derived T-regulatory cell product) to patients with bone marrow failure syndrome. Researchers want to determine the highest possible dose that is safe to be given. Researchers also want to learn if CK0801 may improve the symptoms of bone marrow failure syndrome. Patients enrolled in this study will all have been diagnosed with treatment refractory bone marrow failure syndrome (which includes aplastic anemia, myelodysplastic syndrome, or myelofibrosis). Participants eligible to participate in this study are unable or unwilling to be treated with standard therapy or have failed standard therapy.
Conditions Studied
Interventions
- BIOLOGICAL CK0801
Study Locations (2)
California
- Sarcoma Oncology Research Center, Cancer Center of Southern California - Santa Monica
Texas
- The University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2019-05-30 |
| Est. Completion | 2027-05-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03773393
The ClinicalTrials.gov registry entry for NCT03773393 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cellenkos, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bone Marrow Disease appearing as the primary indexed condition, and to 1 intervention - of which CK0801 is the first listed.
NCT03773393 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Texas.
Frequently Asked Questions
What is clinical trial NCT03773393 about?
NCT03773393 is a clinical study titled "A Clinical Trial of CK0801 (a New Drug) in Patients With Bone Marrow Failure Syndrome (BMF)". The goal of this clinical research study is to determine whether it is safe and practical to give CK0801 (a Cord blood-derived T-regulatory cell product) to patients with bone marrow failure syndrome. Researchers want to determine the highest possible dose that is safe to be given. Researchers also ...
What is the current status of trial NCT03773393?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2019-05-30. Estimated completion is 2027-05-30.
What conditions does trial NCT03773393 study?
This clinical trial studies the following conditions: Bone Marrow Disease.
What interventions are being tested in trial NCT03773393?
The interventions under investigation include: CK0801 (BIOLOGICAL).
Who is sponsoring clinical trial NCT03773393?
This trial is sponsored by Cellenkos, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03773393 being conducted?
This trial has 2 study locations across California, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bone Marrow Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.